Skip to content

PERSPECTIVE THERAPEUTICS, INC.: 10-Q filed 2012-05-15

What PERSPECTIVE THERAPEUTICS, INC. reported in its quarterly report filed 2012-05-15 (fiscal Q3 2012): 30 published measures, 77 facts as tagged in accession 0001144204-12-029499.

This filing

Form
10-Q (quarterly report)
Filed
2012-05-15
Fiscal period
fiscal Q3 2012
Accession
0001144204-12-029499 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All PERSPECTIVE THERAPEUTICS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2012-03-317,590,353USD
At 2011-06-307,888,895USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2012-03-311,439,255USD
At 2011-06-301,436,379USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2012-03-316,151,098USD
At 2011-06-306,452,516USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2012-03-312,524,397USD
At 2011-06-302,112,254USD
At 2011-03-313,475,928USD
At 2010-06-302,990,744USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2012-01-01 to 2012-03-31-552,886USD91
2011-07-01 to 2012-03-31-2,283,946USD275
2011-01-01 to 2011-03-31-1,030,265USD90
2010-07-01 to 2011-03-31-2,130,216USD274

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2011-07-01 to 2012-03-31-1,824,219USD275
2010-07-01 to 2011-03-31-1,808,368USD274

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2011-07-01 to 2012-03-3126,000USD275
2010-07-01 to 2011-03-31105,401USD274

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2011-07-01 to 2012-03-312,305,449USD275
2010-07-01 to 2011-03-312,399,524USD274

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2011-07-01 to 2012-03-31-69,087USD275
2010-07-01 to 2011-03-31-105,972USD274

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2012-03-31-47,029,779USD
At 2011-06-30-44,745,833USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2012-03-312,591,649USD
At 2011-06-303,208,911USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2011-07-01 to 2012-03-3199,568USD275
2010-07-01 to 2011-03-3168,622USD274

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2012-01-01 to 2012-03-31-762,859USD91
2011-07-01 to 2012-03-31-2,657,317USD275
2011-01-01 to 2011-03-31-693,438USD90
2010-07-01 to 2011-03-31-2,196,604USD274

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2012-03-314,006,672USD
At 2011-06-304,221,993USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2012-03-31626,107USD
At 2011-06-30774,198USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2012-03-31853,097USD
At 2011-06-30792,835USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2012-01-01 to 2012-03-31967,079USD91
2011-07-01 to 2012-03-313,126,778USD275
2011-01-01 to 2011-03-311,050,864USD90
2010-07-01 to 2011-03-312,897,547USD274

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2012-03-31441,194USD
At 2011-06-30749,849USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2012-01-01 to 2012-03-31204,220USD91
2011-07-01 to 2012-03-31469,461USD275
2011-01-01 to 2011-03-31357,426USD90
2010-07-01 to 2011-03-31700,943USD274

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2012-01-01 to 2012-03-31132,237USD91
2011-07-01 to 2012-03-31573,212USD275
2011-01-01 to 2011-03-31244,184USD90
2010-07-01 to 2011-03-31374,317USD274

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2012-03-3129,316,306shares
At 2011-06-3026,443,118shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2012-03-3153,159,892USD
At 2011-06-3051,180,237USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2012-03-31299,656USD
At 2011-06-30277,182USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2012-03-31168,509USD
At 2011-06-30141,154USD

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2012-01-01 to 2012-03-31-555,544USD91
2011-07-01 to 2012-03-31-2,291,920USD275
2011-01-01 to 2011-03-31-1,032,923USD90
2010-07-01 to 2011-03-31-2,138,190USD274

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2012-01-01 to 2012-03-31575,832USD91
2011-07-01 to 2012-03-311,726,017USD275
2011-01-01 to 2011-03-31627,592USD90
2010-07-01 to 2011-03-311,784,933USD274

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2012-01-01 to 2012-03-31209,973USD91
2011-07-01 to 2012-03-31373,371USD275
2011-01-01 to 2011-03-31-336,827USD90
2010-07-01 to 2011-03-3166,388USD274

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2010-07-01 to 2011-03-31368,781USD274

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2011-07-01 to 2012-03-3150,006USD275
2010-07-01 to 2011-03-3134,433USD274

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2011-07-01 to 2012-03-31161,103USD275
2010-07-01 to 2011-03-3147,128USD274

Inspect the source

Entity
PERSPECTIVE THERAPEUTICS, INC. / CIK 0000728387
Captured
2026-09-19T15:00:29.793Z
SEC response SHA-256
80792777921b49454c9d29f110283a1024ec5ce2a3749610d4c1319da49650fe

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000728387.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))